Neurotech startup Sychedelic raises $3.5 Mn in seed funding
The startup is building a wearable neurotechnology device designed as premium headphones that combines neuromodulation, biometric sensing, and adaptive artificial intelligence.
Sychedelic has raised $3.5 million (around Rs 31.5 crore) in a seed funding round backed by TurboStart, Ideabaaz, Pravega Ventures, and a group of angel investors from India, the UAE, and the NRI ecosystem.
The startup plans to use the fresh capital to expand manufacturing capabilities, scale research initiatives, strengthen marketing efforts, and support its upcoming global Kickstarter launch scheduled for May 2026.
Founded in 2025 by Ria Rustagi and Bhavya Madan, Sychedelic is building a wearable neurotechnology device designed as premium headphones that combines neuromodulation, biometric sensing, and adaptive artificial intelligence to respond to users’ mental states in real time.
The startup’s device integrates technologies such as transcranial direct current stimulation (tDCS), binaural beats, and heart-rate variability biofeedback to deliver personalised experiences focused on stress management, focus, relaxation, sleep support, and cognitive wellness.
The founders launched the company after identifying gaps in the mental wellness and wearable technology market, particularly around products that move beyond passive health tracking toward active neurological intervention.
Operating between Gurugram and New York, the company said more than 100 early users have tested the device over the past six months, helping refine its hardware systems, neurostimulation mechanisms, and AI-driven adaptive algorithms through real-world feedback.
Sychedelic also stated that it has received approval from the Central Drugs Standard Control Organisation (CDSCO), granting the product medical-device status in India. The startup has additionally filed international patent applications covering its proprietary technology stack and neuroadaptive systems.
The funding comes amid rising investor interest in neurotechnology, AI-powered healthcare devices, and mental wellness solutions as consumers increasingly seek personalised tools focused on cognitive performance and emotional wellbeing.